Breaking News Instant updates and real-time market news.

CTMX

CytomX Therapeutics

$25.29

1 (4.12%)

21:42
07/12/18
07/12
21:42
07/12/18
21:42

CytomX Therapeutics 5.102M share Secondary priced at $24.50

Goldman Sachs, Citi and Barclays acted as joint book running managers for the offering.

  • 13

    Jul

CTMX CytomX Therapeutics
$25.29

1 (4.12%)

03/08/18
JEFF
03/08/18
NO CHANGE
Target $40
JEFF
Buy
CytomX Therapeutics price target raised to $40 from $25 at Jefferies
Jefferies analyst Biren Amin raised his price target for CytomX Therapeutics to $40 following the company's Q4 report and ahead of "multiple readouts" in 2018 expected from CX-072 and CX-2009. The analyst keeps a Buy rating on the shares.
06/01/18
RHCO
06/01/18
INITIATION
Target $38
RHCO
Buy
CytomX Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Peter Lawson initiated CytomX Therapeutics with a Buy rating and $38 price target. In a research note to investors, Lawson said he is "encouraged" by the biopharma validation of CytomX's platform, while the company retains ownership of a major part of its pipeline, and believes ASCO and 2H data validates the CX-072 platform for safety and efficacy. Additionally, Lawson contends that 2H data for CX-2009 will validate the company's strategy of targeting "undruggable" antigens, unlocking two components of CytomX's valuation. Further, he believes three readouts in 2018 -- updated CX-027 data at ASCO, initial Phase 1/2 data from CX-2009 in the second half of the year, and follow-on Phase 1/2 data from CX-072 in the second half -- could be positive for the company.
06/04/18
NOMU
06/04/18
NO CHANGE
NOMU
Buy
CytomX selloff after ASCO presentations 'unfounded,' says Nomura Instinet
After CytomX Therapeutics presented two presentations for its Probody CX-072 at ASCO, Nomura Instinet analyst Christopher Marai said the data "unequivocally demonstrated" that CX-072 is performing as expected and the selloff in the stock is "unfounded." After discussing with study investigators the real-world experience with CX-072, they noted that despite small numbers it was clear that immune-related adverse events typically associated with anti-PD-L1 agents were reduced, added Marai, who reiterates a Buy rating on CytomX shares.
06/04/18
JEFF
06/04/18
NO CHANGE
Target $40
JEFF
Buy
CytomX early data point to some safety differentiation, says Jefferies
Jefferies analyst Biren Amin said he thinks some investors may have sought a better efficacy profile from CX-072. However, he notes that the Yervoy combo data provided at ASCO are in the dose-escalation phase and are in heavily pretreated patients, adding that safety seems improved with the CX-072 plus ipi combo. Amin has a Buy rating and $40 price target on CytomX shares, which are down $5.58, or 22%, to $19.96 in afternoon trading.

TODAY'S FREE FLY STORIES

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

, ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

12:25
10/23/18
10/23
12:25
10/23/18
12:25
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

AGN

Allergan

$185.90

-1.85 (-0.99%)

SAGE

Sage Therapeutics

$118.28

0.25 (0.21%)

ALKS

Alkermes

$39.00

0.14 (0.36%)

ACAD

Acadia

$21.76

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EDU

New Oriental Education

$52.99

-9.76 (-15.55%)

12:22
10/23/18
10/23
12:22
10/23/18
12:22
Downgrade
New Oriental Education rating change  »

Follow-up: New Oriental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

TSLA

Tesla

$279.50

18.47 (7.08%)

12:21
10/23/18
10/23
12:21
10/23/18
12:21
Periodicals
Mox Reports joins Citron in going long Tesla »

Mox Reports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IQV

Iqvia

$119.62

-6.74 (-5.33%)

12:20
10/23/18
10/23
12:20
10/23/18
12:20
Options
Vote of confidence in IQVIA Holdings after earnings »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXE

NexGen Energy

$1.89

-0.085 (-4.30%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Conference/Events
NexGen Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/18
10/23
12:16
10/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEM

Agnico Eagle

$37.18

0.91 (2.51%)

12:15
10/23/18
10/23
12:15
10/23/18
12:15
Options
Agnico Eagle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

EDU

New Oriental Education

$52.96

-9.79 (-15.60%)

12:13
10/23/18
10/23
12:13
10/23/18
12:13
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

AAPL

Apple

$217.24

-3.38 (-1.53%)

, SPOT

Spotify

$146.50

-2.01 (-1.35%)

12:12
10/23/18
10/23
12:12
10/23/18
12:12
Periodicals
Pandora executive admits to late timing of premium offering, VB says »

According to Venture…

AAPL

Apple

$217.24

-3.38 (-1.53%)

SPOT

Spotify

$146.50

-2.01 (-1.35%)

P

Pandora

$8.47

-0.12 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ANFGY

Antofagasta

$0.00

(0.00%)

12:08
10/23/18
10/23
12:08
10/23/18
12:08
Conference/Events
Antofagasta management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MCD

McDonald's

$175.30

8.77 (5.27%)

, CAT

Caterpillar

$118.17

-10.47 (-8.14%)

12:07
10/23/18
10/23
12:07
10/23/18
12:07
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened sharply…

MCD

McDonald's

$175.30

8.77 (5.27%)

CAT

Caterpillar

$118.17

-10.47 (-8.14%)

MMM

3M

$187.86

-13.55 (-6.73%)

UTX

United Technologies

$127.36

0.94 (0.74%)

VZ

Verizon

$57.08

2.12 (3.86%)

TSLA

Tesla

$276.95

15.92 (6.10%)

CDNS

Cadence Design

$45.20

4.58 (11.28%)

PHM

PulteGroup

$22.27

1.39 (6.66%)

AMAT

Applied Materials

$33.16

-0.36 (-1.07%)

MC

Moelis

$42.49

-8.17 (-16.13%)

CNC

Centene

$130.47

-10.865 (-7.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Dec

  • 14

    Dec

  • 12

    Mar

EBMT

Eagle Bancorp

$16.75

-0.75 (-4.29%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Earnings
Eagle Bancorp reports Q3 EPS 30c, two estimate consensus 30c »

"For the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$136.59

-4.05 (-2.88%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Conference/Events
Visa management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

COG

Cabot Oil & Gas

$22.68

-0.48 (-2.07%)

12:05
10/23/18
10/23
12:05
10/23/18
12:05
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BA

Boeing

$346.06

-9.92 (-2.79%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Earnings
Fly Intel: What to watch in Boeing's earnings report »

Boeing (BA) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ACB

Aurora Cannabis

$7.38

(0.00%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
Aurora Cannabis falls -15.0% »

Aurora Cannabis is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDU

New Oriental Education

$53.16

-9.59 (-15.28%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
New Oriental Education falls -15.3% »

New Oriental Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

MC

Moelis

$42.59

-8.07 (-15.93%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
Moelis falls -15.9% »

Moelis is down -15.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ABG

Asbury Automotive

$65.78

6.17 (10.35%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
Asbury Automotive rises 10.3% »

Asbury Automotive is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

DWT

Britannia Bulk

$6.68

0.71 (11.89%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
Britannia Bulk rises 11.6% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$60.75

7.41 (13.89%)

12:00
10/23/18
10/23
12:00
10/23/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 13.9% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$118.92

-9.72 (-7.56%)

11:57
10/23/18
10/23
11:57
10/23/18
11:57
Hot Stocks
Caterpillar CFO: company focused on buyback »

Management said the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

11:56
10/23/18
10/23
11:56
10/23/18
11:56
Conference/Events
Morgan Stanley to hold an analyst/industry conference call on IT trends »

Managing Director Huberty…

CSX

CSX

$66.08

-2.23 (-3.26%)

11:55
10/23/18
10/23
11:55
10/23/18
11:55
Options
CSX put volume heavy and directionally bearish »

Bearish flow noted in CSX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.